Variant report
Variant | rs16843251 |
---|---|
Chromosome Location | chr1:171725830-171725831 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | TEAD4 | chr1:171725337-171725842 | K562 | blood: | n/a | n/a |
2 | RCOR1 | chr1:171725276-171726042 | K562 | blood: | n/a | n/a |
3 | CCNT2 | chr1:171725494-171725874 | K562 | blood: | n/a | n/a |
4 | TAL1 | chr1:171725466-171726097 | K562 | blood: | n/a | chr1:171725679-171725694 |
5 | KAP1 | chr1:171725790-171726628 | K562 | blood: | n/a | n/a |
6 | RCOR1 | chr1:171725442-171725904 | K562 | blood: | n/a | n/a |
7 | POLR2A | chr1:171722769-171728047 | K562 | blood: | n/a | n/a |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:171724145..171725831-chr1:171749285..171750823,2 | K562 | blood: | |
2 | chr1:171709554..171712819-chr1:171724332..171729197,5 | K562 | blood: | |
3 | chr1:171709658..171712904-chr1:171725619..171729545,3 | MCF-7 | breast: | |
4 | chr1:171722184..171727474-chr1:171729363..171734018,7 | K562 | blood: | |
5 | chr1:171723775..171729031-chr1:171729363..171735304,8 | K562 | blood: | |
6 | chr1:171719571..171721308-chr1:171725110..171727162,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000232261 | TF binding region |
ENSG00000271459 | TF binding region |
ENSG00000010165 | Chromatin interaction |
ENSG00000117533 | Chromatin interaction |
ENSG00000236741 | Chromatin interaction |
ENSG00000232261 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs1001373 | 0.81[GIH][hapmap];0.83[JPT][hapmap] |
rs10489249 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.97[ASN][1000 genomes] |
rs10489251 | 0.81[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs10753181 | 0.91[AFR][1000 genomes];0.95[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs10798603 | 0.86[YRI][hapmap] |
rs10913507 | 0.81[AMR][1000 genomes];0.93[EUR][1000 genomes] |
rs10913529 | 0.81[GIH][hapmap];0.83[JPT][hapmap] |
rs10913530 | 0.86[YRI][hapmap] |
rs10913565 | 0.83[JPT][hapmap] |
rs10913578 | 0.88[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];0.93[GIH][hapmap];1.00[JPT][hapmap];0.88[LWK][hapmap];1.00[MEX][hapmap];0.83[MKK][hapmap];1.00[TSI][hapmap];0.96[YRI][hapmap];0.91[AFR][1000 genomes];0.95[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs10913582 | 1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.81[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs10913587 | 0.81[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs11577073 | 0.81[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs11577197 | 0.81[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs11577745 | 1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.81[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs11578699 | 0.81[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs11578723 | 0.81[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs11580522 | 1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.81[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs11583920 | 0.83[JPT][hapmap] |
rs11590680 | 0.81[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs11590714 | 0.81[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs12096984 | 0.90[YRI][hapmap] |
rs12119232 | 0.92[ASN][1000 genomes] |
rs12120152 | 0.86[YRI][hapmap] |
rs12126566 | 0.91[ASN][1000 genomes] |
rs15655 | 0.81[GIH][hapmap] |
rs16843230 | 0.91[AFR][1000 genomes];0.93[AMR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs17649050 | 1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.81[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs17649068 | 0.97[ASN][1000 genomes] |
rs17649250 | 1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap] |
rs2073484 | 0.86[YRI][hapmap] |
rs2227229 | 0.90[YRI][hapmap] |
rs2298914 | 0.83[JPT][hapmap] |
rs2421911 | 0.91[ASN][1000 genomes] |
rs3753539 | 0.88[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];0.92[GIH][hapmap];1.00[JPT][hapmap];0.88[LWK][hapmap];1.00[MEX][hapmap];0.83[MKK][hapmap];1.00[TSI][hapmap];0.96[YRI][hapmap];0.91[AFR][1000 genomes];0.95[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs4342884 | 0.82[YRI][hapmap] |
rs4468194 | 0.86[YRI][hapmap] |
rs6665581 | 0.86[YRI][hapmap] |
rs6670427 | 0.83[CEU][hapmap] |
rs6672082 | 0.85[YRI][hapmap] |
rs6673782 | 0.89[YRI][hapmap] |
rs6674688 | 0.90[YRI][hapmap] |
rs6688447 | 0.83[YRI][hapmap] |
rs6700606 | 0.86[YRI][hapmap] |
rs999685 | 0.86[YRI][hapmap] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | esv14617 | chr1:171016086-171726961 | Enhancers Weak transcription Flanking Active TSS Strong transcription Genic enhancers Active TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 52 gene(s) | inside rSNPs | diseases |
2 | esv3512995 | chr1:171329123-171994470 | Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 56 gene(s) | inside rSNPs | diseases |
3 | esv3512997 | chr1:171329123-171994470 | Strong transcription Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 56 gene(s) | inside rSNPs | diseases |
4 | esv12447 | chr1:171556291-171726822 | Strong transcription Weak transcription Enhancers ZNF genes & repeats Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 23 gene(s) | inside rSNPs | diseases |
SNP | Gene | Cis/trans | Tissue | Source |
---|---|---|---|---|
rs16843251 | VAMP4 | cis | multi-tissue | Pritchard |
rs16843251 | DCAF6 | cis | cerebellum | SCAN |
rs16843251 | VAMP4 | cis | Brain Pons | GTEx |
rs16843251 | DNM3 | cis | cerebellum | SCAN |
rs16843251 | VAMP4 | cis | lymphoblastoid | seeQTL |
rs16843251 | VAMP4 | cis | Frontal Cortex | GTEx |
rs16843251 | METTL13 | cis | parietal | SCAN |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:171723600-171730200 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
2 | chr1:171724200-171727400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr1:171724200-171731400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
4 | chr1:171724400-171726400 | Weak transcription | Fetal Heart | heart |
5 | chr1:171724400-171726400 | Weak transcription | NHEK | skin |
6 | chr1:171724400-171727400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
7 | chr1:171724400-171729600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr1:171724600-171726800 | Enhancers | K562 | blood |